Recently, therapeutic strategies have been devised using multitarget inhibitors that block both MAO and ChE; these studies demonstrated that MAO and AChE inhibitors can improve cognitive function and relieve AD symptoms by increasing the levels of monoamines and choline esters [12, -14]. The gene discussed is ACHE; the disease is Alzheimer disease.